Isosorbide Mononitrato Doc Generici (Isosorbide 5 Mononitrate)

Isosorbide mononitrate, the active ingredient in Isosorbide Mononitrato Doc Generici, is a nitrate vasodilator presented as an oral tablet for oral use. It is used to relieve angina and manage chronic heart failure in adult patients.

GNH USA supplies Isosorbide Mononitrato Doc Generici as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isosorbide mononitrate belongs to the nitrate class and is employed in cardiovascular conditions where vasodilation improves myocardial oxygen supply.

- Stable angina pectoris: reduces the frequency and severity of chest pain episodes by decreasing cardiac workload. - Chronic heart failure: improves exercise tolerance and alleviates symptoms by lowering preload and afterload.

Isosorbide mononitrate may cause a range of adverse reactions, most of which are related to its vasodilatory action.

Common Side Effects: - Headache - Dizziness or light‑headedness - Flushing - Low blood pressure (hypotension) - Nausea - Palpitations

Serious or Rare Side Effects: - Severe hypotension leading to syncope - Myocardial infarction in susceptible patients - Life‑threatening arrhythmias - Anaphylactic or severe allergic reactions - Methemoglobinemia (rare) - Persistent tachycardia

Before initiating therapy, clinicians should evaluate cardiovascular status and consider potential interactions.

- Assess cardiovascular status: monitor blood pressure and heart rate prior to treatment. - Avoid concomitant use with phosphodiesterase‑5 inhibitors: risk of profound hypotension. - Adjust use in renal impairment: exercise caution in severe renal dysfunction. - Educate patients on orthostatic symptoms: advise rising slowly from seated or lying positions. - Store at room temperature: keep in the original container, protect from moisture and light.

Isosorbide mononitrate can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Phosphodiesterase‑5 inhibitors (e.g., sildenafil, tadalafil): may cause severe hypotension. - Other nitrate preparations (e.g., nitroglycerin, isosorbide dinitrate): additive vasodilation. - Sodium nitroprusside: synergistic blood‑pressure lowering effect.

Moderate Interactions (Monitor Closely): - Antihypertensive agents (beta‑blockers, ACE inhibitors, ARBs): may enhance blood‑pressure reduction. - Diuretics: increase the risk of orthostatic hypotension. - Alcohol: can potentiate vasodilatory effects and dizziness.